Dr. Koremans was appointed as President and CEO, Specialty Medicines in April 2013.
Previously, he served as President and Chief Executive Officer of Teva Europe since March 2012.
Prior to joining Teva, Dr. Koremans served as Senior Vice President, Generics, Strategy & Development, Sanofi, and as President and CEO of Zentiva from 2009 until 2011.
Dr. Koremans has held a variety of senior positions in Europe at the Serono Group from 1993 to 2000; Gruenenthal from 2000 to 2007 and Cryo-Save, Europe’s leading stem cell storage company from 2007 to 2009.
Dr. Koremans received his medical degree from the Erasmus University of Rotterdam, the Netherlands in 1988.